[1] |
林彩虹, 袁芃, 高春会. 乳腺交界性叶状肿瘤术后远处移三例报告[J]. 中国肿瘤临床与康复, 2014, 21(8): 937. |
[2] |
王浩, 曹海玲. CD34与SMA在乳腺叶状肿瘤诊断中的作用及病理形态分析[J]. 临床医学, 2015, 35(3): 13. |
[3] |
FENG D, PENG C, LI C, et al. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri[J]. Oncol Rep, 2009, 22(5): 1129. |
[4] |
LIU J J, SHEN R, CHEN L, et al. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker[J]. Int J Clin Exp Pathol, 2010, 3(4): 328. |
[5] |
何朝辉, 唐福才, 曹正国, 等. Piwil2在膀胱尿路上皮癌组织中的表达及临床意义[J]. 现代泌尿生殖肿瘤杂志, 2018, 10(2): 79. doi: 10.3870/j.issn.1674-4624.2018.02.005 |
[6] |
CARTER BA, PAGE DL. Phyllodes tumor of the breast: local recurrenceversus metastatic capacity[J]. Hum Pathol, 2004, 35(9): 1051. doi: 10.1016/j.humpath.2004.08.001 |
[7] |
蒋梅, 柯晓斌. 乳腺叶状囊肉瘤1例报告并文献复习[J]. 现代肿瘤医学, 2014, 22(2): 339. doi: 10.3969/j.issn.1672-4992.2014.02.29 |
[8] |
肖昆, 孙庭. Piwil2与肿瘤的关系及研究进展[J]. 江西医药, 2013, 48(3): 256. doi: 10.3969/j.issn.1006-2238.2013.03.036 |
[9] |
李跃波, 冯定庆, 凌斌, 等. Piwil2基因表达诱导NIH3T3细胞恶性转化[J]. 安徽医科大学学报, 2013, 48(5): 467. |
[10] |
TAUBERT H, WACH S, JUNG R, et al. Piwil2 expression is correlated with disease specific and progression free survival of chemotherapy treated bladder cancer patients[J]. Mol Med, 2015, 21(1): 371. doi: 10.2119/molmed.2014.00250 |
[11] |
SARVESTANI FM, SAFAEI A, TALEI A, et al. The evaluation of cancer testis gene PIWIL2 expression levels as a new prognostic biomarker for breast cancer[J]. Clin Lab, 2016, 62(8): 1469. |
[12] |
贾慧丽, 徐芸. Piwil2基因在肝癌组织中mRNA及蛋白的表达[J]. 世界华人消化杂志, 2012, 20(34): 3385. |
[13] |
POUYANFAR N, MONABBATI A, SHARIFI AA, et al. Expression levels of MMP9 and PIWIL2 in prostate cancer: a case-control study[J]. Clin Lab, 2016, 62(4): 651. |
[14] |
LEE JH, SCHVTTE D, WULF G, et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway[J]. Hum Mol Genet, 2006, 15(2): 201. doi: 10.1093/hmg/ddi430 |
[15] |
FENG D, YAN K, ZHOU Y, et al. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis[J]. Oncotarget, 2016, 7(40): 64575. doi: 10.18632/oncotarget.11810 |